Immix Biopharma
IMMX
IMMX
7 hedge funds and large institutions have $475K invested in Immix Biopharma in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 5 closing their positions.
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$190K |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$132K |
3 |
3
State Street
Boston,
Massachusetts
|
$100K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$11K |
Top Sellers
1 |
1
Renaissance Technologies
New York
|
$0 |
2 |
VF
2
Virtu Financial
New York
|
$0 |
3 |
3
Citadel Advisors
Miami,
Florida
|
$0 |
4 |
XT
4
XTX Topco
George Town,
Cayman Islands
|
$0 |
5 |
5
BlackRock
New York
|
$0 |